RVNC Revance Therapeutics, Inc.: institutional ownership and insider trading

2 funds reported holding $2.72M of Revance Therapeutics, Inc. in their latest 13F filings; in Q2 2025 funds net bought $0, with 0 new positions and 1 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.

Largest institutional holders of RVNC

1. CIGOGNE MANAGEMENT SA — $1.43M
2. Nuveen Asset Management, LLC — $1.29M

Recent RVNC insider trades

• Nov 18, 2024: Hollander David sold 3,908 shares ($16.3K)

5%+ owners

• Teoxane SA: 6.2% (Schedule 13D/A, filed Jan 30, 2025)

All RVNC 13F holders · All RVNC insider trades